Yes: a nurse practitioner, physician assistant or physician can open a cash-pay telemedicine hormone practice in New Jersey, and 2026 changed the picture for NPs. The gating items are a New Jersey license for anyone treating a patient located in the state, a practice structure that satisfies the Board of Medical Examiners rule limiting ownership of health-care services to licensed professionals, a New Jersey Controlled Dangerous Substances registration on top of the DEA number, NJPMP enrollment, and for NPs either qualifying under the March 2026 independent-practice law or keeping a joint protocol with a collaborating physician. A telehealth-only entity may also need to register with the Department of Health. This is a 2026 planning summary, not legal advice; confirm every point with the New Jersey Board of Nursing, the State Board of Medical Examiners, the Division of Consumer Affairs and counsel, because rules change.
New Jersey practice authority: who can run and own a telemedicine hormone practice
Nurse practitioners in New Jersey
For years New Jersey was a reduced practice state: an advanced practice nurse could diagnose and treat independently but could prescribe only under a written joint protocol with a collaborating physician under N.J.S.A. 45:11-49, reviewed and re-signed at least annually. Pandemic executive orders waived the protocol, and those waivers finally expired on April 2, 2026.
The permanent change is S2996/A4052, signed March 30, 2026 and effective on signing. As commonly summarized, an APN with more than 5,000 hours of clinical practice in a qualifying population focus (family or individual across the lifespan, adult-gerontology, pediatrics, women’s health or behavioral health) who provides primary or behavioral health care may practice and prescribe without a joint protocol. The law carries conditions: at least 14 hours of controlled-substance pharmacology education before prescribing controlled drugs, at least 10 hours of pharmacology continuing education each biennial renewal, malpractice coverage at levels comparable to physicians, and notice duties to the Board of Nursing. It expressly excludes general obstetrics and elective aesthetic or cosmetic services.
Two questions matter for a hormone practice. First, whether a cash-pay hormone-optimization clinic fits the “primary care” framing or risks being read as an excluded elective service; the statute does not answer that cleanly, so put the question to the Board of Nursing and counsel before you rely on independent status. Second, an APN who has not reached the hour threshold, or whose population focus does not qualify, still needs a joint protocol with a collaborating physician to prescribe, as the rules are commonly read. Either way the APN needs a New Jersey RN license, APN certification, a separate New Jersey CDS registration and a DEA registration to prescribe testosterone, which is Schedule III.
Physician assistants in New Jersey
PAs are licensed by the Board of Medical Examiners and practice only under physician supervision. Supervision must be continuous but does not require physical presence as long as the physician is reachable electronically. The PA signs a separate written delegation agreement with each supervising physician defining scope, the supervisory ratio is generally four PAs to one physician unless the Board approves otherwise, and prescribing, including controlled substances, is delegated under N.J.S.A. 45:9-27.19 and N.J.A.C. 13:35-2B.12, with the PA’s own New Jersey CDS and DEA registrations. The PA is presumed to be the agent of the supervising physician, so the physician carries disciplinary exposure for the PA’s practice. The pandemic waivers that suspended these requirements ended April 2, 2026, and no recent statute has loosened PA supervision as far as public records show.
Physicians and the corporate practice of medicine
New Jersey does not have a single corporate-practice statute; the doctrine lives mainly in the Board of Medical Examiners rule N.J.A.C. 13:35-6.16. As commonly read, a health-care service must be owned solely by licensed health-care professionals unless another state license allows otherwise. Permitted forms are solo practice, a partnership, a professional association or professional corporation under the Professional Service Corporation Act (N.J.S.A. 14A:17-1 et seq.), or a limited liability company composed solely of licensees in the same or a closely allied field. A physician may be employed by a general business corporation only in listed settings such as licensed facilities and HMOs, so an investor-owned clinic employing the physician is not an option.
Non-licensed partners sit in a management services organization. The rule allows a general business corporation to supply non-professional services such as office management, staffing, space and billing, provided the licensee keeps sole control over medical policy and patient fees and the company does not advertise licensed services under its own name. Management fees should be fair-market-value compensation for defined services; percentage-of-collections fees draw fee-splitting and self-referral scrutiny under the Board’s rules and the Codey Law (N.J.S.A. 45:9-22.4 et seq.). Have a New Jersey health-care attorney paper the MSO agreement.
So who may own the practice?
A physician may own it outright. Nursing is listed among the closely allied professions in the Board rule, so a physician-APN co-owned LLC or professional association is a recognized structure. An APN-owned practice under Board of Nursing jurisdiction is common in New Jersey and, for an APN qualifying under the 2026 law, no longer needs a physician in the chart; whether a specific cash-pay hormone model fits is the question to clear with counsel first. PAs are not on the closely allied list as commonly read, so a PA generally builds the business through an MSO alongside a physician-owned clinical entity. Spouses and investors who hold no license belong in the MSO.
New Jersey telehealth rules for a remote hormone practice
Licensure and patient location. Under N.J.S.A. 45:1-61 et seq., a provider delivering telemedicine to a patient located in New Jersey must be licensed by the relevant New Jersey board and remains subject to New Jersey jurisdiction. There is no telehealth registration for individual out-of-state practitioners. Physicians licensed elsewhere can use the Interstate Medical Licensure Compact; the Nurse Licensure Compact covers the RN license only, so an APN still needs New Jersey APN certification.
Organization registration. Separately, N.J.S.A. 45:1-64 and N.J.A.C. 8:53 require an organization formed primarily to furnish telehealth or telemedicine to register annually with the Department of Health before it begins services; law-firm summaries put the fee at $1,500 a year. Private practices with a physical treatment location are exempt as commonly read, so a telehealth-only hormone clinic should assume it must register and confirm with the Department.
Standard of care and consent. The telemedicine standard of care is the same as in person, and if telemedicine cannot meet it the provider must direct the patient to in-person care. Services are generally delivered by real-time, two-way audio-video; audio-only or store-and-forward is allowed where the standard of care can still be met. Before an initial encounter the provider reviews the patient’s history and records. Consent may be oral, written or digital as the standard of care allows, the patient must be able to reach the provider or a substitute for at least 72 hours after a visit, and follow-up or emergency referral must be arranged where needed. No in-person exam is required by the telemedicine statute before a first video visit.
Controlled substances. Testosterone is Schedule III. New Jersey’s in-person requirement in N.J.S.A. 45:1-62(e), which demands an initial in-person exam and one at least every three months, applies to Schedule II drugs, and the state applies it regardless of continuing federal flexibilities. The rule that bites a hormone practice is N.J.A.C. 13:35-7.9 on anabolic steroids and human growth hormone: a practitioner may prescribe only within a bona fide relationship, after a full medical history, a full medical examination and documentation of a valid medical need, never for muscle building, athletic or cosmetic purposes. How a “full medical examination” is satisfied in a telemedicine workflow is a question to settle with the Board and counsel before the first prescription. Federal DEA telemedicine flexibilities currently run through December 31, 2026 and have been extended repeatedly, so check the federal position too.
Registrations and NJPMP. New Jersey requires its own Controlled Dangerous Substances registration from the Division of Consumer Affairs Drug Control Unit, renewed annually, in addition to the DEA registration; a board license does not substitute, and the registration is tied to a New Jersey practice location, so an out-of-state prescriber typically needs a New Jersey address. Every prescriber must enroll in the NJPMP. Checks are mandatory for Schedule II drugs, opioids and benzodiazepines; for other controlled drugs such as testosterone they are encouraged rather than required as commonly read, and checking before every controlled prescription is sound practice. New Jersey also generally requires electronic prescribing, so an EHR with certified EPCS is a baseline.
See the full 12-week program →
Entity options, registered agent and New Jersey taxes
Physicians typically form a professional association or professional corporation under the Professional Service Corporation Act, or an LLC whose members are all licensees in the same or closely allied field; New Jersey does not use a separate “PLLC” label. An APN practice generally files an LLC or professional corporation; any MSO is an ordinary LLC. Filings go through the Division of Revenue and Enterprise Services, and every entity names a registered agent with a New Jersey street address. Typical figures to confirm: a formation fee in the low hundreds of dollars and an annual report fee of about $75.
New Jersey taxes pass-through income at graduated gross-income-tax rates that top out at 10.75 percent, and a partnership or multi-member LLC with more than two owners pays a $150-per-owner filing fee. An entity taxed as a corporation pays Corporation Business Tax at rates that generally run 6.5 to 9 percent depending on income. The Business Alternative Income Tax election can help owners with the federal state-tax deduction cap. Treat all of this as typical and confirm with a New Jersey CPA.
Labs and pharmacy in New Jersey
New Jersey is one of the states that restricts direct-to-consumer laboratory testing: under N.J.A.C. 10:61-1.6 a clinical laboratory generally performs testing only on the explicit order of a physician or other licensed practitioner, so patients cannot self-order a hormone panel, and several national lab marketplaces exclude New Jersey. That does not hinder a clinic: the practice orders the panel under its own account with a national laboratory, the patient visits a nearby draw site, and results return to the EHR.
On the pharmacy side, an out-of-state pharmacy that ships into New Jersey must hold an out-of-state pharmacy registration from the New Jersey Board of Pharmacy, renewed annually, with a home-state inspection report from the past two years and, for sterile compounding, documented USP 797 compliance. Note the compounding affidavit: some registered pharmacies have attested that they will not ship compounded preparations into New Jersey. Ask any compounder for its New Jersey registration and whether it is cleared to ship compounded sterile preparations, which includes injectable testosterone, and keep a New Jersey-based 503A compounder as a backup.
New Jersey at a glance
| Item | New Jersey (confirm with the board or counsel) |
|---|---|
| NP practice authority | Independent practice and prescribing for APNs with 5,000+ hours in a qualifying population focus providing primary or behavioral care (2026 law); otherwise joint protocol with a collaborating physician |
| PA model | Continuous physician supervision (remote allowed); written delegation agreement per physician; 4:1 ratio; delegated prescribing incl. CDS |
| Corporate practice of medicine | Licensee-only ownership under N.J.A.C. 13:35-6.16; PA/PC or LLC; MSO for non-clinical services at fair market value |
| Telehealth registration | None for individuals (full NJ license required); telehealth-only organizations register annually with the Department of Health |
| In-person exam before prescribing | Not required by the telemedicine statute for Schedule III; required for Schedule II; steroid rule requires a full medical examination |
| State controlled-substance registration | Yes, annual NJ CDS registration from the Division of Consumer Affairs plus DEA |
| PDMP check | NJPMP enrollment mandatory; checks mandatory for Schedule II, opioids and benzodiazepines; encouraged for all CDS |
| Direct-to-consumer labs | Restricted; practitioner order required; clinic orders under its own account |
| State tax | Gross income tax up to 10.75%; $150-per-owner partnership fee; CBT 6.5–9% for corporations |
The 12-week Clinic In A Box map applied to New Jersey
Clinic In A Box™ is a private, 1-on-1, done-with-you 12-week build led by an operator-mentor who runs active telemedicine clinics in the US, Colombia and Australia. The New Jersey items land in the weeks shown.
- Weeks 1–4, Foundation. Niche and patient avatar; ownership model (physician entity, physician-APN co-ownership, APN practice or MSO) settled with counsel against N.J.A.C. 13:35-6.16; entity filed and registered agent named; New Jersey license confirmed and any multi-state pathway started; APN independent-practice eligibility checked or a collaborating physician and joint protocol in place; PA delegation agreement drafted; NJ CDS registration, DEA registration, NJPMP enrollment and NPI; Department of Health telemedicine-organization registration queued; HIPAA framework, BAAs, and an EHR with EPCS and New Jersey consent language.
- Weeks 5–8, Operations. Intake and telemedicine consent built to N.J.S.A. 45:1-62; the steroid-rule workflow (history, examination, documented medical need) written into the prescribing protocol; 72-hour contact and follow-up referral steps; lab account opened and New Jersey draw sites mapped; compounding pharmacies vetted for New Jersey registration and compounding clearance; cash-pay service menu, subscription option and payment processing live.
- Weeks 9–12, Launch. Patient acquisition for North and South Jersey and the New York and Philadelphia commuter belts (Google Business where eligible, referrals, organic search); soft launch and first patients seen; revenue and retention tracking; a 90-day roadmap including annual CDS, NJPMP, pharmacy and Department of Health renewals and, where applicable, the annual joint-protocol review.
By week 12 the practice has a compliant New Jersey entity, its registrations, a configured EHR, lab and pharmacy relationships, a priced service menu and its first patients. Read the telemedicine hormone clinic compliance guide for the national layer under these New Jersey rules, and how to start a telemedicine hormone clinic for the full sequence. New Jersey NPs can start with the nurse practitioner practice startup program page; physicians should read the physician telemedicine practice launch program page. The investment is $10,000 for two hours a week of direct work plus messaging between sessions; details are on the Clinic In A Box™ program page.
Frequently asked questions
Can a nurse practitioner open a telemedicine hormone clinic in New Jersey without a physician?
Possibly, as of 2026. An APN with more than 5,000 clinical hours in a qualifying population focus who provides primary or behavioral health care may practice and prescribe without a joint protocol under the law signed March 30, 2026, subject to pharmacology education, physician-level malpractice coverage and Board of Nursing notice duties. Whether a cash-pay hormone practice fits that framing rather than the excluded elective-service category is a question for the Board of Nursing and counsel; an APN who does not qualify still needs a joint protocol with a collaborating physician to prescribe.
Does New Jersey require an in-person visit before prescribing testosterone by telemedicine?
The telemedicine statute’s in-person requirement applies to Schedule II drugs, and testosterone is Schedule III. However, the Board of Medical Examiners’ anabolic-steroid rule requires a bona fide relationship, a full medical history, a full medical examination and a documented medical need before any steroid prescription, and bars prescribing for muscle building or cosmetic purposes. Confirm with the Board and counsel how the examination requirement is met in a video-first workflow, and check the current federal telemedicine rules for controlled substances.
Do I need a New Jersey CDS registration in addition to my DEA number?
Yes. New Jersey requires a separate Controlled Dangerous Substances registration from the Division of Consumer Affairs for anyone who prescribes controlled drugs in the state, renewed annually and tied to a New Jersey practice location; NPs and PAs hold their own. You also need NJPMP enrollment and, for most prescriptions, electronic prescribing. Confirm current fees and forms with the Drug Control Unit.
Can I treat New Jersey patients from another state?
Only with a full New Jersey license for your profession; New Jersey has no telehealth registration for individual out-of-state practitioners, and jurisdiction attaches when the patient is in the state. Physicians can shorten the path through the Interstate Medical Licensure Compact; APNs apply to the Board of Nursing directly. Plan for a New Jersey practice address for the CDS registration, and if the entity exists primarily to deliver telehealth, register it with the Department of Health before seeing patients.
Request your free info session
The next step is a free 30-minute info session covering your credential, your New Jersey licensing and practice-authority situation, your timeline and whether this is the right vehicle. Either way you leave with a clearer picture of what to do next. Call 844-734-2112 or use the form below.